EWTX
Edgewise Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$43.07
+2.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 23.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.44x
- Price / sales
- —
- Price / cash flow
- -29.34x
Enterprise value
- Enterprise value
- $4.2B
- EV / sales
- —
- EV / EBITDA
- -21.40x
- EV / EBIT
- -19.28x
- Market cap
- $4.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026